GSK recalls Panadol® Advance in Puerto Rico

GlaxoSmithKline Consumer Healthcare is one of the world's largest over-the-counter consumer healthcare products companies.GlaxoSmithKline is voluntarily recalling four lots ofPanadol® Advance 100 count pain relief products from Puerto Rico consumers, because the product did not meet the federal child-resistant closure requirement. Panadol® Advance 100 ct contains acetaminophen (paracetamol), and so the bottle requires a child-resistant packaging or to be labeled as a product "for households without young children" according to the Poison Prevention Packaging Act. As the product does not have a child resistant cap, there is a risk of unintentional ingestion and overdose.

The lot numbers being recalled are 14241,14002,13881 and 13801. These were manufactured in the U.S. and were sold in Puerto Rico from November 2012 to February 2014. Panadol® Advance with Optizorb tablets are used for fast and effective relief of headaches, toothache, backache, rheumatic and muscle pains, and period pain. It also relieves the aches and pains of cold and flu, sore throat pain and helps to reduce temperature.

According to FDA,80,000 people in the U.S. overdose on acetaminophen each yearand about 500 cases are fatal.General Manager for GSK Consumer Healthcare in Puerto Rico said that while the product is safe to use as directed, consumers must keep the product away from children.